Freerk van Dijk is a researcher at the University of Groningen's Faculty of Medical Sciences, Department of Genetics, with a strong focus on genomic and epigenetic research. He is actively involved in major research consortia including BIOS Consortium and Brain MEND Consortium, contributing to large-scale population studies that advance our understanding of genetic and epigenetic factors in human health. His research expertise centers on DNA methylation, genome-wide association studies, and genetic variation analysis, with particular emphasis on how these factors influence complex traits and diseases. Dr. van Dijk's work often integrates computational approaches with biological insights to develop interpretable models for phenotype prediction and disease mechanism understanding. His recent publications demonstrate a strong trend toward multi-omics integration, combining different layers of biological data to improve prediction accuracy and biological interpretability. His research spans diverse areas including neurology (ALS research), cardiovascular genetics, and the genetic basis of neurological traits like left-handedness. Dr. van Dijk contributes significantly to large collaborative projects such as the Lifelines Biobank, a major population study in the Netherlands. His work has been cited extensively, with some publications receiving over 60 citations, and has garnered attention from news outlets, social media, and academic platforms like Mendeley.
